Recent research highlights the effectiveness of biologics, such as anti-tumor necrosis factor (TNF)-α, IL-12/23 p40, IL-23 p19, and IL-17, in treating PPP/PAO [5]. This evidence concerns the gene IL17A and palmoplantar pustulosis.